Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
Pharma's 'urgent need for reinvention': PwC's call to action
PwC has laid out bold ambitions for what it believes drugmakers could achieve by 2035, as well as steps those companies should start taking in 2026.
Fraiser Kansteiner
Jan 8, 2026 6:00am
InduPro nabs 2nd Big Pharma deal with $950M Lilly pact
Jan 7, 2026 3:52pm
Study finds HIV can evolve to resist lenacapavir—at a cost
Jan 7, 2026 2:00pm
Pfizer maps out $865M Cartography discovery deal
Jan 6, 2026 7:30am
Gilead garners lipid package for cancer asset in $300M pact
Jan 6, 2026 7:00am
NIH instability grows with exit of longtime neuro director
Jan 2, 2026 2:16pm
